Innovation for Health - 13 February 2020
Contact Global Investor Forum I4H Bootcamp
Innovation for Health - Shaping the future of healthcare

Thijn Brummelkamp

Co-founder, Scenic Biotech

Thijn Brummelkamp studied biology at the Free University in Amsterdam and did his graduate studies at The Netherlands Cancer Institute (in the group of René Bernards). After his PhD he was appointed as group leader (Whitehead Fellow) at the Whitehead Institute for Biomedical Research in Cambridge, USA. In 2011 his laboratory moved to the Netherlands Cancer Institute in Amsterdam.
Thijn Brummelkamp develops and uses genetic technologies to identify genes that are relevant for human disease. For example an approach for genetics in haploid human cells was developped and used to identify the entry receptor for Ebola virus (Carette et al, Nature, 2011), to reognize a new step in the picornavirus life cycle (Staring et al, Nature, 2017), to assign Vasohibins as long-sought enzymes modifiers of the cytoskeleton (Nieuwenhuis et al, Science 2017) and to implicate genes in pathways relevant for cancer immunotherapy (Mezzadra et al, Nature, 2017; Logtenberg et al, Nature Medicine, 2019).

He was chosen as one of the world's top 35 Young Innovators by MIT's Technology Review Magazine (2005), received EMBO’s Gold Medal 2013 and the KNAW Ammodo award (2015). Thijn Brummelkamp is a co-founder of 3 biotech companies, Haplogen Genomics (acquired in 2015 by Horizon Discovery UK), Haplogen (partnered in 2018 with Bayer to develop antiviral agents) and Scenic Biotech B.V. (founded in 2017).

Title: From basic research to application

The abstract will follow soon.
Marcel Levi
University College London Hospitals
Jan van de Winkel
Annemarie Jorritsma
Ton Rijnders
Koen Kas
UGhent & HealthSkouts
Rajiv Vaid Basaiawmoit
Aarhus University & Biosymfonix

Claudia Rijcken

Inge Huitinga
Netherlands Brain Bank
Wiro Niessen
Erasmus MC, TU Delft & Quantib
Els Beirnaert
Aelin Therapeutics
Joep Muijrers
PureTech Health
Koenraad Wiedhaup
McKinsey & Company
Esther Talboom-Kamp
Saltro Diagnostics
Elise Meijer
Antwerp Management School & Accenture Strategy
Carine van den Brink
Axon Lawyers
Tim Knotnerus
AgomAb Therapeutics
Sjaak Vink
Hans Schikan
Topsector Life Sciences & Health
Thijn Brummelkamp
Scenic Biotech
Nadine Rouleaux
Maastricht University
Charlotte Kluit
Dharminder Chahal
SkylineDx, Van Herk Investments, Swanbridge

Marianne van der Steen
RegMedXB & Maastricht University

Jan de Kerpel
Kempen & Co
Wim Van Hecke
Wiesje van der Flier 
Alzheimercentrum Amsterdam
Niels Prins
Marco Blom
Alzheimer Nederland
Edwin Moses
Achilles Therapeutics & Evox Therapeutics
Carl Moons
Health Innovation Initiative Holland
Jan Kimpen
Linda van de Burgwal 
Vrije Universiteit Amsterdam
Onno van de Stolpe
Ton van der Steen
Erasmus MC, Medical Delta & STW
Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Media sponsor
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.